Thus, the NONHSAT079852.2/hsa–mir-10401-3p–HSPA1A axis may be one of the potential mechanisms that promote GBM recurrence and is a potential therapeutic target for controlling and treating GBM. Here, HSPA1A is linked to glioblastoma.